Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01423019 · ClinicalTrials.gov registry record · NA
A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition
A NA study of Weight Loss, sponsored by Integrative Health Technologies.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT01423019: Completed NA study of Weight Loss, sponsored by Integrative Health Technologies.
NCT01423019 is a NA study of Weight Loss that has completed, run by Integrative Health Technologies. The registered enrollment target is 75 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01423019, a NA study of Weight Loss, has completed, sponsored by Integrative Health Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)
Primary Outcome
This study goes beyond assessing changes in scale weight and BMI. DXA is used to assess changes in body composition (lean, fat and bone) associated with the weight loss interventions.
Conditions Studied
Interventions
- OTHER Sugar pill
- DIETARY_SUPPLEMENT Advantra Z
- DIETARY_SUPPLEMENT Advantra Z + Naringin + Hesperiden
Study Locations (1)
Texas
- Integrative Health Technologies, Inc. - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2011-10 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01423019 record still lists
NCT01423019 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 3 interventions - of which Sugar pill is the first listed.
NCT01423019 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01423019 about?
NCT01423019 is a clinical study titled "A Comparative Effectiveness Study Evaluating the Effects of Thermogenic Supplements on Body Composition". The purpose of this study is to determine whether subjects taking a supplement designed to increase metabolic rate will have a positive effect on body composition (fat mass, muscle mass, and bone density.)
What is the current status of trial NCT01423019?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2011-10. Estimated completion is 2012-01.
What conditions does trial NCT01423019 study?
This clinical trial studies the following conditions: Weight Loss.
What interventions are being tested in trial NCT01423019?
The interventions under investigation include: Sugar pill (OTHER), Advantra Z (DIETARY_SUPPLEMENT), Advantra Z + Naringin + Hesperiden (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01423019?
This trial is sponsored by Integrative Health Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01423019 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01423019's enrollment target sits among peer trials
75 61st of 116 higher than 56 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia